Tbc1d1 is a Rab GTPase-activating protein (GAP) implicated in regulating intracellular retention and cell surface localization of the glucose transporter GLUT4 and thus glucose uptake in a phosphorylation-dependent manner. Tbc1d1 is most abundant in skeletal muscle but is expressed at varying levels among different skeletal muscles. Previous studies with male Tbc1d1-deficient (Tbc1d1 Ϫ/Ϫ ) mice on standard and high-fat diets established a role for Tbc1d1 in glucose, lipid, and energy homeostasis. Here we describe similar, but also additional abnormalities in male and female Tbc1d1 Ϫ/Ϫ mice. We corroborate that Tbc1d1 loss leads to skeletal muscle-specific and skeletal muscle type-dependent abnormalities in GLUT4 expression and glucose uptake in female and male mice. Using subcellular fractionation, we show that Tbc1d1 controls basal intracellular GLUT4 retention in large skeletal muscles. However, cell surface labeling of extensor digitorum longus muscle indicates that Tbc1d1 does not regulate basal GLUT4 cell surface exposure as previously suggested. Consistent with earlier observations, female and male Tbc1d1
TBC1D1 is a Rab GTPase-activating protein (GAP) that belongs to a family of proteins with homologous TBC (Rab GAP) domains named after similar domains found in the tre-2 oncogene and the yeast cell cycle regulators BUB2 and cdc16 (23) . Under in vitro conditions, the GAP domain of Tbc1d1 catalyzes the hydrolysis of GTP to GDP in Rabs 2A, 8A, 8B, 10, and 14 (25) and thus inactivates them. Rabs regulate membrane trafficking (36), and a likely role for Tbc1d1 is thus to regulate the intracellular movement of membrane proteins by modifying the activity of Rabs. Indeed studies in cultured L6 myoblasts and myotubes (15) and in rat skeletal muscle (1) established a role for Tbc1d1 in controlling the cell surface localization of the insulin-regulated glucose transporter GLUT4 and glucose uptake. Thereby, Tbc1d1 and its Rab GAP activity were essential for intracellular retention of GLUT4, whereas Tbc1d1 phosphorylation was required for the release of GLUT4 to the cell surface and concomitant increased glucose uptake (1, 15) .
GLUT4 is the major glucose transporter in muscle and fat cells, and the regulation of GLUT4 cell surface expression is key to the control of glucose uptake into muscle and fat cells and thus whole-body glucose homeostasis. Under fasting conditions, GLUT4 predominantly localizes to intracellular compartments, and glucose uptake into muscle and fat cells is limited to spare glucose as fuel for the brain. GLUT4 relocates to the cell surface in response to different stimuli, most prominently insulin and exercise, promoting increased glucose uptake for storage and to meet increased energy demands (20) . Insulin and exercise elicit phosphorylation of Tbc1d1 on multiple recognition sites for Akt and AMP-activated protein kinase in skeletal muscle (32, 33) . Tbc1d1 is most abundant in skeletal muscle (5, 31, 32) but is expressed at dissimilar levels among different skeletal muscles (31, 32 ) (see below). Tbc1d1 is also expressed in other tissues that regulate whole-body glucose and energy homeostasis, including brain and pancreas (32) . However, white and brown adipose tissues, liver, and heart express relatively low levels of Tbc1d1 (5, 6, 31, 32) . Tbc1d1 tissue distribution thus suggests that it can only be responsible for regulating GLUT4 trafficking in some skeletal muscle and not in adipose tissues. Furthermore, the role of Tbc1d1 is very likely not restricted to skeletal muscle and to the regulation of GLUT4 trafficking.
To establish the physiological function of Tbc1d1, we analyzed mice in which Tbc1d1 was deleted. While our work was in progress, four other studies with different Tbc1d1 knockout mice were published (5, 8, 30, 31) . In the first study, a naturally occurring 7-bp deletion in the Tbc1d1 gene leading to the loss of Tbc1d1 protein was identified, and this was found to be responsible for a leaner phenotype of SJL mice on a high-fat diet (5) . Studies on glucose homeostasis were then performed on chow-fed C57BL/6J mice with the SJL mutation (31) . A third study characterized energy, lipid, and glucose homeostasis in chow-and high-fat diet-fed C57BL/6J mice in which Tbc1d1 was deleted using a gene trap insertion (8) . The fourth study focused on exercise-regulated glucose metabolism in C57BL/6 mice in which Tbc1d1 was eliminated using another gene trap insertion (30) . These studies were performed with young male mice only (5, 8, 30, 31) or did not specify the sex of the mice used for most experiments (30) . Our study complements these earlier reports and adds new information on female as well as older chow-fed Tbc1d1-deficient (Tbc1d1 Ϫ/Ϫ ) mice on another strain background (C57BL/6N) harboring a different mutation causing Tbc1d1 deletion.
MATERIALS AND METHODS

Generation of Tbc1d1
Ϫ/Ϫ mice. A C57BL/6N embryonic stem (ES) cell clone with a gene trap insertion in the first intron of the Tbc1d1 gene (nucleotide position 64,237,180; gene accession no. NM_019636) was identified by Texas Institute for Genomic Medicine (TIGM, College Station, TX) in a high-throughput random-mutagenesis approach as described previously (41) . The ES cell clone was used to generate mice heterozygous for the Tbc1d1 mutation (Tbc1d1 ϩ/Ϫ ) by TIGM. We purchased and bred these to obtain mice homozygous (Tbc1d1 Ϫ/Ϫ ) and heterozygous (Tbc1d1 ϩ/Ϫ ) for the Tbc1d1 mutation and wild-type (Tbc1d1 ϩ/ϩ ) littermates. Mice were genotyped by PCR on genomic DNA isolated from mouse tail snips using DirectPCR Lysis Reagent (Viagen Biotech). The gene-specific forward primer common to both alleles was 5=-GAAGAGATGTGT-GAGCTCTGTTGG-3= (GP1, Fig. 1A ), the gene-specific reverse primer for the wild-type allele was 5=-TCCACTCAACCCAACTAC-CTATCC-3= (GP2, Fig. 1A ), and the reverse primer for the knockout allele (derived from the LTR sequence in the gene trap vector) was 5=-CCAATAAACCCTCTTGCAGTTGC-3=. Primers were obtained from Integrated DNA Technologies. PCR was performed using all three primers in the same reaction, each at 0.6 M, with MyTaq Red DNA Polymerase (catalog no. BIO 21108, Bioline) and Mg 2ϩ at 1.75 mM. For PCR amplification, the following conditions were used: initial denaturation at 95°C for 2 min followed by 12 cycles with denaturation at 94°C for 15 s, annealing at 60°C for 30 s, and extension at 72°C for 30 s; 30 cycles with denaturation at 94°C for 15 s, annealing at 58°C for 60 s, and extension at 72°C for 30 s; and a final extension at 72°C for 5 min. The PCR products were separated on 1.8% agarose gels in Tris Borate EDTA buffer (130 mM Tris base, 45 mM boric acid, and 2.5 mM EDTA). The PCR products with expected sizes of 255 bp for the wild-type and 220 bp for the Tbc1d1 mutant allele were visualized with SybrGold (Molecular Probes). The DNA size standard used was a low-molecular-weight DNA ladder from New England Biolaboratories (catalog no. N-3233S).
All Tbc1d1 Ϫ/Ϫ and Tbc1d1 ϩ/ϩ mice used for the studies described here were offspring of heterozygous breeder pairs and were matched for age and sex in each experiment. Mice were housed under temperature-and humidity-controlled conditions under a constant 12-h:12-h light/dark cycle with free access to water and chow (catalog no. 7912 Teklad LM-485, Harlan Laboratories). All animal procedures were approved by the University of Virginia Institutional Animal Care and Use Committee.
Preparation of tissue homogenates, immunoblotting, and immunoprecipitation. Tissue homogenates were prepared in homogenization buffer (25 mM Hepes, pH 7.4, 100 mM NaCl, 1 mM Na 3VO4, 20 mM sodium pyrophosphate, 3 mM N-ethylmaleimide, 1 g/ml pepstatin, 10 M EP475, 10 g/ml aprotinin, and 0.2 mM PMSF) as described previously (19) . SDS samples were prepared, protein concentrations determined, and samples containing equal amounts of protein separated by SDS-PAGE. GLUT1 and GLUT4 immunoblots showing the insertion site for the Omnibank Gene Trap Vector 76 (consisting of the ␤-Gal neomycin resistance selection marker flanked by a splice acceptor, a poly-A transcription termination sequence, and retroviral LTR sequences) (41) . ATG start and stop sites are marked on top, and exon numbers are given on bottom. B: genotyping. Gene-specific primers flanking the gene trap vector insertion site in the Tbc1d1 gene (arrows labeled GP1 and GP2 in A) together with a primer derived from the LTR sequence in the vector were used for genotyping by PCR. Single PCR products of 255 and 220 bp were obtained from tail genomic DNA of Tbc1d1 ϩ/ϩ (ϩ/ϩ) and Tbc1d1 Ϫ/Ϫ (Ϫ/Ϫ) mice, respectively, differentiating these from heterozygous Tbc1d1 ϩ/Ϫ (ϩ/Ϫ) with both PCR products. C: expression of Tbc1d1 in skeletal muscles. Tissue homogenates in SDS sample buffer (25 g total protein/lane) of extensor digitorum longus (EDL), soleus (Sol), tibialis anterior (TA), gastrocnemius (Gastro), and quadriceps (Quad) muscles isolated from 12-14-wk-old male (M) and female (F) Tbc1d1 ϩ/ϩ and Tbc1d1 Ϫ/Ϫ mice were immunoblotted with Tbc1d1 antibodies. D: body weights (BW) were determined for 12-15-wk-old female (n ϭ 26) and male (n ϭ 11) Tbc1d1 Ϫ/Ϫ (solid bars) and Tbc1d1 were carried out as described previously (19) . Tbc1d1 immunoblots were carried out with polyclonal Tbc1d1 (V796) antibodies (catalog no. 4629, Cell Signaling Technology) following the manufacturer's instructions and using chemiluminescence (Lumigen ECL Ultra, catalog no. TMA-100, Lumigen) for detection. Carnitine palmitoyltransferase 1B (CPT1B) and fatty acid translocase cluster of differentiation 36 (CD36) immunoblots were carried out with polyclonal anti-CPT1 antibody H40 (catalog no. sc98834, Santa Cruz Biotechnology), and anti-CD36 EPR6573 antibodies (catalog no. ab133625, Abcam) and using chemiluminescence for detection (Lumigen ECL Ultra). The ChemiDoc-IT 500 imaging system (Ultra-Violet Products) was used to detect and quantify signals on Tbc1d1, CPT1B, and CD36 immunoblots. Immunoblots were stained with Ponceau S (0.1% Ponceau S in 5% acetic acid) to confirm equal total protein loading. Glucose uptake and GLUT4 subcellular distribution. Glucose uptake assays in isolated adipocytes and skeletal muscles and subcellular fractionation of gastrocnemius and quadriceps muscles were performed as described previously (19) . Subcellular fractions were immunoblotted with GLUT4 antibodies as described previously (19) . Total membranes were also immunoblotted with CD36 antibodies as described above. Cell surface labeling of GLUT4 was also carried out as described previously (19) with the exception that extensor digitorum longus (EDL) muscles were labeled and the biotinylated membrane-impermeant compound used for cell surface labeling was Bio-SS-ATB-BGPA corresponding to N-
-bis(D-glucopyranos-4-yloxy)-2-propylamine (kindly provided by Dr. Geoffrey Holman, University of Bath, Bath, United Kingdom) (12) . This compound differs from the previously used Bio-LC-ATB-BGPA (19) in that the biotin label is attached through a disulfide bond. Because of this modification, the precipitated glucose transporters could be released from the streptavidin beads by incubation in SDS sample buffer with 10% ␤-mercaptoethanol for 10 min at room temperature without heating.
RNA preparation and determination of GLUT4 mRNA. Total RNA was isolated from tibialis anterior muscles, and GLUT4 mRNA levels were determined by real-time quantitative PCR as described previously (19) . A standard curve was obtained by running reactions with four different amounts of total RNA for one of the Tbc1d1 ϩ/ϩ samples (10.00, 5.00, 2.50, and 1.25 ng). Relative levels of GLUT4 mRNA were derived from this standard curve.
Glucose and insulin tolerance tests and analysis of blood glucose and plasma insulin. These tests and measurements were performed as previously described (19) except that plasma insulin values during a glucose tolerance test were measured using the Stellux Chemi Rodent Insulin ELISA kit (catalog no. 80-INSMR-CH01, ALPCO). Glucose disposal in adipose and skeletal muscle tissues and glucose incorporation into glycogen in liver in vivo during a glucose tolerance test were also carried out as described (19) .
Determination of body composition, energy expenditure, and respiratory exchange ratio. For body composition measurements, mice were anesthetized with a mixture of ketamine (100 mg/kg body wt) and xylazine (10 mg/kg body wt) and subjected to total body imaging in a dual energy X-ray absorptiometry (DEXA) machine (GE Lunar PIXImus II densitometer). Lean and fat mass were determined using PIXImus software. For determination of energy expenditure and respiratory exchange ratios, mice were placed in an Oxymax metabolic chamber system (Comprehensive Laboratory Animal Monitoring System, CLAMS, from Columbus Instruments), and oxygen consumption (V O2), carbon dioxide production (V CO2), food and water intake, and ambulatory activity were determined for each mouse every 15 min over 72 h. The mice were allowed to adjust to the cages during the first 12 h, and measurements taken during the following 48 h (12-60 h of the run) for each mouse were used for data analysis. Respiratory exchange ratios (RER) were calculated as the ratio of carbon dioxide production to oxygen consumption (V CO2/V O2).
Measurement of fatty acid oxidation by skeletal muscle. Fatty acid oxidation was carried out using fresh gastrocnemius muscle homogenates as described (13) with the following modifications for CO 2 collection. Mitochondrial samples were added to reaction buffer in wells of a 24-well plate (catalog no. 3526, Corning). A PCR tube (with the rim and cap cut off) containing 50 l 2 M NaOH was added to the wells, and the plate was sealed with PCR sealing film (catalog no. T-2417-5, BioExpress, ThermalSeal). The plate was incubated in a 37°C water bath for 1 h without shaking. At the end of the incubation period, 1 M perchloric acid was injected into the reactions using a 23-gauge needle, avoiding the PCR tube. The plate was resealed and incubated at room temperature for another hour. The 50 l of 2 M NaOH that absorbed the CO 2 produced during incubation was added to liquid scintillation fluid and counted. Because it was necessary to use fresh homogenates immediately after homogenization for assaying fatty acid oxidation, homogenates derived from paired Tbc1d1
Ϫ/Ϫ and Tbc1d1 ϩ/ϩ were processed simultaneously, and results (dpm/g protein) were compared between the pairs.
Lipid-loading test. The test was performed as described (3) . Briefly, mice were fasted for 4 h before the test (7:00 -11:00 AM). Olive oil (6 l/g body wt) was given by oral gavage. Blood was collected before (time 0) and at 1, 2, 3, and 4 h after gavage. Triglyceride levels in serum were measured using a triglyceride determination kit (catalog no. TR0100, Sigma). Free fatty acids (FFA) in serum were determined using HR series NEFA-HR2 reagents (Wako Life Sciences). For measurements of unabsorbed lipids in stool samples, feces were collected for 5 h after olive oil gavage while the mice were kept in NALGENE mouse metabolic cages. Fecal samples were dried, ground to a fine powder, suspended in Folch solution (4:1 chloroform: methanol), and incubated at 55°C for 1 h. Samples were then filtered and dried at 55°C under nitrogen. After reconstitution in 90% isopropanol/10% Triton X-100, triglyceride concentration in samples was measured using the triglyceride determination kit.
Avidin pulldown for determination of acetyl-CoA carboxylase 2 expression in skeletal muscle. Gastrocnemius and tibialis anterior muscles were dissected and immediately homogenized in the abovedescribed tissue homogenization buffer. An aliquot of the homogenate containing 4 mg of protein was diluted 1:2 into NP-40 buffer (50 mM Tris·HCl, pH 7.4, 150 mM NaCl, 10% glycerol, 1% NP-40, 10 mM NaF, 20 mM NaPP, 1 mM Na 3VO4, 1 g/ml pepstatin, 10 M EP475, 10 g/ml aprotinin, and 10 M leupeptin, final concentrations) and incubated for 30 min on ice. Insoluble material was pelleted by centrifugation at 16,000 g for 20 min at 4°C. The supernatant was added to 50 l of a 1:1 slurry of avidin agarose beads (catalog no. 20219, Pierce) in NP-40 buffer, and the mix was incubated overnight at 4°C while rotating. Beads were pelleted and washed in NP-40 buffer, and the biotin-containing proteins that were absorbed by the avidin beads (including acetyl-CoA carboxylases, ACCs) were released into SDS sample buffer. Samples were processed for the detection of ACC2 as described (14) .
Preparation of mitochondria. Crude mitochondria were prepared from pooled gastrocnemius and quadriceps muscles as described (17) with the exception that the isolated minced muscles were incubated for 2 min at 4°C with Nagarse proteinase (1 mg/ml) (catalog no. P8038, Sigma) in isolation medium before homogenization. The crude mitochondria were further purified as described (39) . The purified mitochondria were immunoblotted with CD36 antibodies as described above.
Statistical analysis. Statistical analysis was performed with GraphPad Prism software. One-sample t-tests with Tbc1d1 ϩ/ϩ basal assigned values of 100 or 1, unpaired two-tailed t-tests, and two-way ANOVAs were used to compare data (means Ϯ SE) as specified in figure legends. Differences were considered statistically significant for P values Ͻ0.05. P values between 0.05 and 0.10 are given in figures and table to indicate strong trends.
RESULTS
Growth and development of Tbc1d1
Ϫ/Ϫ mice. C57BL/6N mice heterozygous for an insertion of a retroviral trapping vector (gene trap) in the first intron of the Tbc1d1 gene locus on mouse chromosome 5 ( Fig. 1A) were bred to obtain homozygous (Tbc1d1 Ϫ/Ϫ ), heterozygous (Tbc1d1
), or wildtype (Tbc1d1 ϩ/ϩ ) mice for experiments (Fig. 1B) . To ensure that Tbc1d1 protein was eliminated in the Tbc1d1
Ϫ/Ϫ mice, we immunoblotted different skeletal muscles for Tbc1d1 (Fig.  1C) . Tbc1d1 was clearly missing in all Tbc1d1
Ϫ/Ϫ skeletal muscles examined, thus validating the mice with the gene trap insertion as Tbc1d1 Ϫ/Ϫ mice. Consistent with previous reports (31, 32) , Tbc1d1 is differentially expressed between different skeletal muscles in wild-type mice. It is most abundant in tibialis anterior and EDL and is less expressed in gastrocnemius and quadriceps and least in soleus muscles. Similar Tbc1d1 levels were present in the different skeletal muscles derived from female and male mice.
The different genotypes in the offspring of the heterozygous breeder pairs were obtained with the expected Mendelian distribution (Tbc1d1
Ϫ/Ϫ ϭ 24%:48%: 28%, n ϭ 533). This excluded the possibility that Tbc1d1 deficiency led to increased embryonic lethality. Also, Tbc1d1
Ϫ/Ϫ and Tbc1d1 ϩ/Ϫ mice did not show any gross developmental abnormalities. Growth as determined by measuring body length was normal for both male and female Tbc1d1 Ϫ/Ϫ mice (data not shown). However, female Tbc1d1 Ϫ/Ϫ mice had lower body weights and smaller parametrial fat depots compared with female Tbc1d1 ϩ/ϩ mice ( Fig. 1 , D and E, and Table 1 ). Fat pad weight-to-body weight ratios were similar between the two genotypes, consistent with similar body composition for Tbc1d1 Ϫ/Ϫ and Tbc1d1 ϩ/ϩ mice determined by DEXA (Fig. 1F ). For male Tbc1d1
Ϫ/Ϫ and Tbc1d1 ϩ/ϩ mice body weights, fat pad weights, fat pad weight-to-body weight ratios, and body composition measured by DEXA were all not significantly different ( Fig. 1, D-F) . In summary, loss of Tbc1d1 does not lead to developmental abnormalities. Female, but not male, Tbc1d1 Ϫ/Ϫ mice have lower body weights with proportionally smaller perigonadal fat depots.
Glucose uptake ex vivo and GLUT4 expression in Tbc1d1
Ϫ/Ϫ skeletal muscles and adipocytes. Glucose uptake was determined in isolated EDL and soleus muscles and adipocytes of female and male mice (Fig. 2 , A-C). In female and male Tbc1d1 Ϫ/Ϫ EDL, insulin-stimulated glucose uptake was reduced by 26 and 32%, respectively, while basal glucose uptake was normal ( Fig. 2A) . In Tbc1d1 Ϫ/Ϫ soleus ( Fig. 2B ) and Tbc1d1 Ϫ/Ϫ adipocytes ( Fig. 2C ) glucose uptake under both basal and insulin-stimulated conditions were similar to wildtype in females and males. Concomitantly, GLUT4 protein levels were decreased by 40 and 58% in female and male Tbc1d1 Ϫ/Ϫ EDL, respectively, compared with Tbc1d1
EDL, but they were similar to wild-type in female and male Tbc1d1 Ϫ/Ϫ soleus and Tbc1d1 Ϫ/Ϫ white adipose tissue (Fig.  2D ). Normal GLUT4 expression was also observed in female and male brown adipose tissue (Fig. 2D) . However, GLUT4 protein expression was reduced in all additional skeletal muscles examined, in tibialis anterior by 32 and 57%, in gastrocnemius by 30 and 37%, and in quadriceps by 48 and 24% in female and male mice, respectively (Fig. 2D ). When measuring GLUT4 mRNA levels in tibialis anterior of male mice, we found that they were similar between Tbc1d1
Ϫ/Ϫ and Tbc1d1 ϩ/ϩ mice (1.7 Ϯ 0.18 vs. 1.2 Ϯ 0.31, n ϭ 3, P ϭ 0.21). These results suggest that Tbc1d1 plays a role in regulating glucose uptake and GLUT4 protein expression in most, but not all, skeletal muscles and not in adipocytes. This is consistent with the differential expression of Tbc1d1 in different skeletal muscles and low abundance of Tbc1d1 in adipose tissues (5, 31, 32) (Fig. 1C ). GLUT4 expression is decreased less in skeletal muscle of female Tbc1d1
Ϫ/Ϫ compared with male Tbc1d1 Ϫ/Ϫ mice with the exception of quadriceps muscle, in which a more pronounced decrease in GLUT4 is observed in females. These differential changes in GLUT4 expression cannot be explained by differences in Tbc1d1 expression in skeletal muscles of female and male wild-type mice.
Subcellular distribution of GLUT4 in skeletal muscles of Tbc1d1
Ϫ/Ϫ mice. GLUT4 translocation to the cell surface involves multiple steps, including movement to and docking and fusion of GLUT4-containing vesicles (GLUT4 vesicles) with the plasma membrane (20) . To obtain insight into how Tbc1d1 deletion affected GLUT4 translocation, we performed subcellular fractionation of the large skeletal muscles gastrocnemius and quadriceps (gastro/quad) (Fig. 3 , A-C) and cell surface labeling with the small EDL muscle (Fig. 3, D-F) . With the former approach, we analyzed whether GLUT4 vesicles are released to the plasma membrane and to what extent Values are means Ϯ SE. Blood glucose (BG) and plasma insulin (Ins) were measured in random-fed and fasted female and male Tbc1d1 Ϫ/Ϫ (Ϫ/Ϫ) and Tbc1d1 ϩ/ϩ (ϩ/ϩ) mice at ages 8 -11 wk (young female and male) and 10 -11 mo (older female and male). Body weights (BW) shown were measured in the same mice after determination of blood glucose and insulin under random-fed conditions. Values for Tbc1d1 Ϫ/Ϫ mice marked with asterisks (*) are statistically significantly different from respective values for Tbc1d1 ϩ/ϩ mice with P Ͻ 0.05 (unpaired 2-tailed t-tests), whereas other marked values were close to being statistically significantly different; †P ϭ 0.06, ‡P ϭ 0.08, and §P ϭ 0.09. in the absence of Tbc1d1. With the latter approach, we determined whether GLUT4 vesicles could fuse with the plasma membrane without Tbc1d1. Because of technical limitations relating to the amount of material needed and accessibility of insulin and the cell surface label to skeletal muscle fibers, subcellular fractionation could only be performed with large skeletal muscle with and without insulin treatment of mice in vivo and cell surface labeling only with small skeletal muscles incubated with and without insulin ex vivo. Only male mice were used for subcellular fractionation, as they yield more material for analysis. Only female EDL muscles were analyzed for GLUT4 cell surface expression because of cost.
After subcellular fractionation, similar amounts of GLUT4 were detected in gastro/quad plasma membranes isolated from
Tbc1d1
Ϫ/Ϫ and Tbc1d1 ϩ/ϩ mice under basal conditions (Fig.  3A) . In response to insulin, there was a significant (1.5-fold) increase in GLUT4 in Tbc1d1 ϩ/ϩ plasma membranes, whereas there was a small (1.1-fold) but not significant increase in Tbc1d1 Ϫ/Ϫ plasma membranes (Fig. 3A) . GLUT4 levels in total membranes of gastro/quad were reduced by 10% in Tbc1d1 ϩ/ϩ mice after insulin stimulation and 29 and 35% in Tbc1d1 Ϫ/Ϫ mice under basal and insulin-stimulated conditions, respectively, compared with basal Tbc1d1 ϩ/ϩ mice (Fig. 3B) . When taking these decreases in total GLUT4 into account (Fig. 3C) , we found that, under basal conditions, the relative amount of GLUT4 in Tbc1d1 Ϫ/Ϫ plasma membranes was increased by 1.3-fold to a level that was lower than in Tbc1d1
Ϫ/Ϫ and Tbc1d1 ϩ/ϩ plasma membranes after insulin stimulation. Insu- lin increased the relative amount of GLUT4 by 1.7-and 1.2-fold, respectively, in Tbc1d1 ϩ/ϩ and Tbc1d1 Ϫ/Ϫ plasma membranes, resulting in similar relative levels of GLUT4.
Cell surface labeling demonstrated that GLUT4 cell surface exposure was decreased by 66% and 51%, respectively, under basal and insulin-stimulated conditions in Tbc1d1 Ϫ/Ϫ EDL (Fig. 3D) . However, because, in the same basal and insulintreated Tbc1d1
Ϫ/Ϫ EDL, total GLUT4 protein expression was decreased by 51 and 54%, respectively (Fig. 3E) , the relative amount of GLUT4 at the cell surface was not significantly reduced in Tbc1d1 Ϫ/Ϫ EDL under basal and insulin-stimulated conditions (Fig. 3F) . Cell surface GLUT4 significantly increased in both Tbc1d1
Ϫ/Ϫ and Tbc1d1 ϩ/ϩ EDL in response to insulin (Fig. 3, D and F) , but the fold increase was more pronounced in Tbc1d1 Ϫ/Ϫ than in Tbc1d1 ϩ/ϩ EDL (2.5 Ϯ 0.3-fold vs. 1.7 Ϯ 0.21-fold, P ϭ 0.04, n ϭ 6).
Thus, subcellular fractionation of gastro/quad indicates that Tbc1d1 deletion leads to increased relative GLUT4 plasma membrane association under basal conditions. However, as cell surface labeling of EDL suggests, this is not associated with increased cell surface exposure of GLUT4. But note, since different skeletal muscles were analyzed by subcellular fractionation and cell surface labeling, we cannot exclude the possibility that GLUT4 movement to the plasma membrane and cell surface exposure are regulated differently in different skeletal muscles.
Whole-body glucose homeostasis and insulin sensitivity in Tbc1d1
Ϫ/Ϫ mice. To determine the effect of Tbc1d1 deletion on glucose homeostasis and insulin sensitivity, we measured glucose and insulin levels under fasting and fed conditions in young and old male and female Tbc1d1 Ϫ/Ϫ and Tbc1d1 ϩ/ϩ mice (Table 1) , performed glucose and insulin tolerance tests (Fig. 4) , and determined glucose uptake in different tissues during a glucose tolerance test (Fig. 5) .
In young and old male and female Tbc1d1 Ϫ/Ϫ and Tbc1d1 ϩ/ϩ mice, blood glucose levels under random fed conditions and after 6 h of fasting were similar with one exception; old male Tbc1d1 Ϫ/Ϫ mice after 6 h of fasting had increased blood glucose levels compared with male Tbc1d1 ϩ/ϩ mice of the same age (Table 1) . Interestingly, when mice were subjected to anesthesia after 6 h of fasting (in preparation for isolation of skeletal muscles for subcellular fractionations), we Ϫ/Ϫ (solid bars) mice and incubated without or with 130 nM insulin, and muscles were processed for cell surface labeling with the biotinylated membrane-impermeable compound Bio-SS-ATB-BGPA. Representative immunoblots for cell surface GLUT4 (derived from entire streptavidin precipitates) and for total GLUT4 (in 20 -25 g total membrane protein), respectively, are shown in top panels under D and E. Signals on immunoblots were quantified and numbers for cell surface GLUT4 corrected for total membrane protein input. Data were expressed as relative levels of Tbc1d1 ϩ/ϩ Bas (assigned a value of 1), and means Ϯ SE (n ϭ 6) were plotted (bar graphs below respective immunoblots under D and E). The ratios of cell surface/total GLUT4 were calculated, and data (means Ϯ SE, n ϭ 6) were plotted (F). Statistical symbols are the same as A-C.
observed increased blood glucose levels in both female and male Tbc1d1 Ϫ/Ϫ mice (Fig. 4A ). Plasma insulin levels were similar for young and old male and female Tbc1d1 Ϫ/Ϫ and Tbc1d1 ϩ/ϩ mice under random fed conditions except that, in older male Tbc1d1 Ϫ/Ϫ mice, insulin levels trended lower compared with age-matched male Tbc1d1 ϩ/ϩ mice ( Table  1) . After 6 h of fasting, plasma insulin levels were lower in young and old female Tbc1d1 Ϫ/Ϫ mice than in their female Tbc1d1 ϩ/ϩ littermates, whereas young and old male Tbc1d1 Ϫ/Ϫ and Tbc1d1 ϩ/ϩ mice showed similar plasma insulin levels (Table 1) .
Young and old female Tbc1d1 Ϫ/Ϫ mice showed subtle but statistically significant impairments in glucose tolerance (see Fig. 4B , left, for results from older female mice; Fig. 5F for results from younger female mice). Insulin tolerance was normal in young Tbc1d1 Ϫ/Ϫ female mice (data not shown) but was mildly impaired in older Tbc1d1 Ϫ/Ϫ female mice (Fig. 4C,  left) . Male Tbc1d1 Ϫ/Ϫ mice did not show any significant abnormalities in glucose or insulin tolerance at a young (data not shown) or older age (Fig. 4, B, right, and C, right) .
Impaired glucose tolerance in female Tbc1d1
Ϫ/Ϫ mice and reduced plasma insulin levels in male and female Tbc1d1 Ϫ/Ϫ mice under some conditions (Table 1 ) could indicate defects in insulin secretion. However, insulin levels at different time points after glucose injection in Tbc1d1 Ϫ/Ϫ mice were similar as in Tbc1d1 ϩ/ϩ mice for both female and male mice (Fig. 4D) .
As described above, we observed EDL-specific impairment of insulin-stimulated glucose uptake in Tbc1d1 Ϫ/Ϫ mice ex vivo (Fig. 2, A-C) . To determine whether glucose uptake in skeletal muscle and adipose tissues is also differentially affected in vivo, we injected unlabeled glucose (to stimulate the release of insulin) or saline together with radioactive tracer glucose into female mice. We found that glucose uptake was increased 1.6-fold in Tbc1d1 Ϫ/Ϫ tibialis anterior compared with Tbc1d1 ϩ/ϩ tibialis anterior under basal conditions and thus equaled glucose uptake in tibialis anterior of Tbc1d1 ϩ/ϩ mice injected with glucose (Fig. 5A) . Glucose-injected Tbc1d1 Ϫ/Ϫ mice further increased glucose uptake by 1.5-fold in tibialis anterior. In Tbc1d1 Ϫ/Ϫ EDL, glucose uptake was similar to Tbc1d1 ϩ/ϩ EDL under basal conditions but was increased 1.2-fold compared with Tbc1d1 ϩ/ϩ EDL after glucose treatment (Fig. 5B) . In gastrocnemius, glucose uptake was similar between Tbc1d1 Ϫ/Ϫ and Tbc1d1 ϩ/ϩ mice treated with saline or glucose (Fig. 5C ). In Tbc1d1 Ϫ/Ϫ brown adipose tissue, basal glucose uptake was decreased by 43% compared with Tbc1d1 ϩ/ϩ brown adipose tissue but was normal after glucose injection (Fig. 5D) . Glucose incorporation into glycogen in liver was similar between Tbc1d1 Ϫ/Ϫ and Tbc1d1 ϩ/ϩ mice treated with saline or glucose (Fig. 5E ). Figure 5F shows that blood glucose levels in saline-treated Tbc1d1 Ϫ/Ϫ and Tbc1d1 ϩ/ϩ mice were similar. However, glucose-treated Tbc1d1 Ϫ/Ϫ mice showed a subtle but significant impairment in glucose tolerance. A previously published study evaluated were fasted for 6 h (8:00 AM to 2:00 PM) and then anesthetized with Nembutal (50 g/g body wt) in preparation for isolation of skeletal muscles for subcellular fractionation. BG levels were determined before euthanasia 30 min later in anesthetized mice. *P Ͻ 0.05, unless noted otherwise, comparing data for Tbc1d1 Ϫ/Ϫ and Tbc1d1 ϩ/ϩ with unpaired 2-tailed t-tests. B: glucose tolerance tests were performed after overnight fasting with 10 -11-mo-old female (n ϭ 5-6) and male (n ϭ 7) Tbc1d1 Ϫ/Ϫ (dashed lines) and Tbc1d1 ϩ/ϩ mice (solid lines). BG levels were measured before (time 0) and after intraperitoneal injection of glucose (2 mg/g body wt) at 10, 20, 30, 60, 90, and 120 min. BGs (means Ϯ SE) were graphed. Data were statistically significantly different for female mice (P Ͻ 0.0001, 2-way ANOVA) but not for male mice. C: insulin tolerance tests were performed on 10 -11-mo-old random-fed female (n ϭ 5-6) and male (n ϭ 7) Tbc1d1 Ϫ/Ϫ (dashed lines) and Tbc1d1 ϩ/ϩ mice (solid lines) at 2:00 PM. BG levels were measured before (time 0) and after an intraperitoneal injection of insulin (0.75 U/kg body wt) at 15, 30, 45, and 60 min. BG in % of BG at time 0 (means Ϯ SE) were graphed. Data were statistically significantly different for female (P ϭ 0.016, 2-way ANOVA) but not for male mice. BWs for Tbc1d1 ϩ/ϩ and Tbc1d1 Ϫ/Ϫ mice used in these tests were similar (data not shown). Insulin and glucose tolerance tests were also performed with 13-19-wk-old female and 9 -14-wk-old male mice. Data were similar as shown for older mice with the exception of a normal insulin tolerance test in young female Tbc1d1 Ϫ/Ϫ mice. D: insulin secretion during glucose tolerance test. Glucose tolerance tests were performed with 19 -22-wk-old female and 21-wk-old male Tbc1d1 Ϫ/Ϫ (dashed lines) and Tbc1d1 ϩ/ϩ mice (solid lines) as described above under B, but blood for glucose and insulin measurements was only taken at 0, 10, and 30 min. Insulin levels at different time points are shown (means Ϯ SE, n ϭ 5-9 for females, n ϭ 8 for males). The data were not statistically significant different for female and male mice over the entire time course (2-way ANOVA) and for individual time points (unpaired 2-tailed t-tests). BG values at the same time points were also not statistically significantly different (data not shown). BWs for Tbc1d1 ϩ/ϩ and Tbc1d1 Ϫ/Ϫ mice used in these tests were similar (data not shown).
glucose uptake in different skeletal muscles and other tissues during a euglycemic hyperinsulinemic clamp in male Tbc1d1 Ϫ/Ϫ mice (31). The observations of increased glucose uptake in tibialis anterior and EDL, normal glucose uptake in gastrocnemius and brown adipose tissue, and normal glucose disposal in liver after insulin stimulation were similar to our findings in female Tbc1d1 Ϫ/Ϫ mice after glucose injection. GLUT4 is the most abundant glucose transporter expressed in skeletal muscle and determines basal and insulin-stimulated glucose uptake (27) . As described above, GLUT4 expression was decreased in tibialis anterior, gastrocnemius, and EDL. Despite these decreases, glucose uptake was still increased in tibialis anterior and EDL and normal in gastrocnemius. To determine whether GLUT1 compensated for decreased GLUT4 expression, we immunoblotted tibialis anterior and gastrocnemius homogenates for GLUT1. We observed similar GLUT1 protein levels between the two genotypes (data not shown). Thus GLUT1 did not compensate for decreased GLUT4 in skeletal muscle.
In conclusion, glucose homeostasis is impaired in Tbc1d1
mice when challenged by fasting (male), with stress induced by anesthesia (female and male), or glucose loading (female). This is not due to impaired glucose disposal in skeletal muscle, adipose tissue, and liver. It is also not the result of impaired insulin secretion. The in vivo like the ex vivo glucose uptake data show selective abnormalities in glucose uptake in the absence of Tbc1d1 compatible with differential Tbc1d1 tissue distribution (5, 31, 32) (Fig. 1C) . However, changes in EDL differ between the in vivo and ex vivo experiments; insulinstimulated glucose uptake is increased in the former and decreased in the latter. Energy and lipid homeostasis. When performing metabolic cage studies, we observed increased V O 2 for female and male Tbc1d1 Ϫ/Ϫ mice ( Fig. 6A) 
and decreased RER in female Tbc1d1
Ϫ/Ϫ mice during light and dark cycles (Fig. 6B) . Tbc1d1 Ϫ/Ϫ and Tbc1d1 ϩ/ϩ male mice showed similar RER (Fig. 6B) . All other parameters measured in the metabolic cages, V CO 2 , total activity, food and water intake, and heat production, were similar between the two genotypes with the exception that male Tbc1d1 Ϫ/Ϫ mice showed a trend to increased food intake during the dark cycle (999.2 Ϯ 3.9 vs. 898.3 Ϯ 4.8 mg/g body wt, n ϭ 10 -12, P ϭ 0.13).
Decreased RER in female Tbc1d1 Ϫ/Ϫ mice indicated increased whole-body fatty acid oxidation. Tbc1d1 is expressed in large skeletal muscles that, because of their mass, are a major site of energy expenditure and fatty acid oxidation. When determining fatty acid oxidation by measuring CO 2 production from oleate using fresh gastrocnemius muscle homogenates, we found that it was increased ϳ1.3-fold for female and male Tbc1d1 Ϫ/Ϫ mice (Fig. 6C) . To evaluate whether, concomitant with increased fatty acid oxidation, lipid clearance was increased, we performed lipid-loading tests. We observed that male Tbc1d1 Ϫ/Ϫ mice cleared triglycerides (Fig.  6D) and FFA (Fig. 6E) GU in vivo in skeletal muscle and adipose tissues. The amount of radioactive 2-deoxy-glucose-phosphate, representing 2-deoxy-glucose taken up into cells, was determined, and GU was expressed in nmol/g tissue per min. Graphs show means Ϯ SE (n ϭ 3-7) for TA (A), EDL (B), gastro (C), and BAT (D). E: glucose incorporation into glycogen in liver was determined by measuring deoxy-D- [1,2- 3 H]-glucose associated with liver glycogen, and data (means Ϯ SE, n ϭ 4 -5) expressed as g/g per min were plotted. Data were compared with unpaired 2-tailed t-tests, and significant differences (P Ͻ 0.05, unless indicated otherwise) are as follows: *comparing data to Tbc1d1 ϩ/ϩ Sal, ٙ comparing data for Tbc1d1 Ϫ/Ϫ Sal and Tbc1d1 Ϫ/Ϫ Gluc to Tbc1d1 ϩ/ϩ Gluc, and #comparing data between Tbc1d1 Ϫ/Ϫ Sal and Tbc1d1 Ϫ/Ϫ Gluc. F: BG levels (means Ϯ SE, n ϭ 4 -7) during the tests are shown for saline-treated Tbc1d1 Ϫ/Ϫ (dashed line and OE) and Tbc1d1 ϩ/ϩ (solid line and ) and glucose-injected Tbc1d1 Ϫ/Ϫ (dashed line and }) and Tbc1d1 ϩ/ϩ (solid line and ). Significant differences were observed between glucose-injected Tbc1d1 Ϫ/Ϫ and Tbc1d1 ϩ/ϩ mice (P ϭ 0.0009 2-way ANOVA) but not between saline-treated Tbc1d1 Ϫ/Ϫ and Tbc1d1 ϩ/ϩ mice. There were no significant differences in BWs between the respective groups of saline-treated Tbc1d1 Ϫ/Ϫ and Tbc1d1 ϩ/ϩ and glucose-injected Tbc1d1 Ϫ/Ϫ and Tbc1d1 ϩ/ϩ mice.
mice after olive oil gavage. In females, lipid levels rose barely (triglycerides) (Fig. 6D) or not (FFA) (Fig. 6E ) after oil gavage but similarly in Tbc1d1 Ϫ/Ϫ and Tbc1d1 ϩ/ϩ mice. No significant differences in triglyceride and FFA levels at time 0 (after 4 h of fasting) were observed between Tbc1d1 Ϫ/Ϫ and Tbc1d1 ϩ/ϩ female and male mice. To ascertain that the lower circulating lipid levels in male Tbc1d1 Ϫ/Ϫ mice after lipid loading were not attributable to a defect in lipid absorption from the gut, we measured triglyceride levels in feces excreted over 5 h after olive oil gavage. They did not differ between
Tbc1d1
Ϫ/Ϫ and Tbc1d1 ϩ/ϩ mice (0.64 Ϯ 0.22 mg vs. 0.44 Ϯ 0.13 mg, n ϭ 7-8, P ϭ 0.47, male 18 -20 wk old).
To further evaluate at which step Tbc1d1 may regulate fatty acid oxidation, we evaluated the expression of known enzymes that are rate limiting for fatty acid oxidation, ACC2 and CPT1B, in gastrocnemius. Because fatty acid oxidation was similarly affected in female and male Tbc1d1 Ϫ/Ϫ mice, only male mice were analyzed. No differences in protein expression of ACC2 and CPT1B were observed in gastrocnemius muscles isolated from Tbc1d1
Ϫ/Ϫ and Tbc1d1 ϩ/ϩ mice (Fig. 6F ). Fatty Ϫ/Ϫ and Tbc1d1 ϩ/ϩ mice with unpaired 2-tailed t-tests. C: fatty acid oxidation was determined using gastrocnemius homogenates prepared from 17-26-wk-old female and 15-28-wk-old male Tbc1d1 Ϫ/Ϫ (solid bars) and Tbc1d1 ϩ/ϩ (open bars) mice. The results (CO2 production corrected for total protein in samples) from experimentally paired Tbc1d1 Ϫ/Ϫ and Tbc1d1 ϩ/ϩ mice (n ϭ 5 and n ϭ 7 pairs for female and male, respectively) were evaluated and the data for Tbc1d1 ϩ/ϩ in each pair assigned a value of 1. Means Ϯ SE of fold increase of Tbc1d1 Ϫ/Ϫ over Tbc1d1 ϩ/ϩ are shown. *P Ͻ 0.05 comparing data using a 1-sample t-test with Tbc1d1 ϩ/ϩ assigned a value of 1. D and E: lipid gavage. Female and male Tbc1d1 Ϫ/Ϫ (dashed lines, OE) and Tbc1d1 ϩ/ϩ (solid lines, ) mice at 14 -33 and 11-19 wk of age, respectively, were given olive oil by gavage, and blood was taken before (time 0) and after 1, 2, 3, and 4 h for the determination of serum total triglyceride (TG) (D) and free fatty acid (FFA) (E) levels. Means Ϯ SE (n ϭ 7-13 and n ϭ 12 for female and male mice, respectively) of TG and FFA levels are shown. The results were significantly different for TG and FFA levels at P Ͻ 0.0001 and 0.022, respectively (2-way ANOVA) for male mice. The results were not different between female Tbc1d1 Ϫ/Ϫ and Tbc1d1 ϩ/ϩ mice. F: expression of rate-limiting proteins in fatty acid oxidation. Skeletal muscle from male Tbc1d1 Ϫ/Ϫ (solid bars) and Tbc1d1 ϩ/ϩ mice (open bars) was used for the detection of acetyl-CoA carboxylase 2 (ACC2), carnitine palmitoyltransferase 1B (CPT1B), and cluster of differentiation 36 (CD36) as following. ACC2 was isolated by avidin pulldown using gastrocnemius and TA homogenates (4 mg total protein) obtained from 14 -15-wk-old mice (n ϭ 3-4) and detected with streptavidin IR dye 800. Results for gastrocnemius are shown. Similar results were obtained with TA muscle. CPT1B was detected in gastrocnemius homogenate (40 g total protein per lane) obtained from 8 -9-wk-old mice (n ϭ 3). CD36 content was analyzed in total membranes (TM CD36) (10 g protein/lane) obtained from pooled gastrocnemius and quadriceps muscles of 10 -16-wk-old mice (n ϭ 4) during subcellular fractionation or in mitochondria (Mito CD36) isolated from 24-wk-old male (n ϭ 4). Top: representative results for 2 samples for each genotype. Bottom: quantitations of respective signals on immunoblots (means Ϯ SE, n ϭ 3-4) in % of Tbc1d1 ϩ/ϩ (with 1 of the Tbc1d1 ϩ/ϩ samples assigned a value of 100%). The data were not statistically significantly different between Tbc1d1 Ϫ/Ϫ and Tbc1d1 ϩ/ϩ mice using unpaired 2-tailed t-tests (ACC2, CPT1B, and Mito CD36) and 1-tailed t-test with Tbc1d1 ϩ/ϩ assigned a value of 100 (TM CD36).
acid translocase CD36 in the plasma membrane and outer mitochondrial membrane has been shown to be important in regulating fatty acid oxidation by importing long-chain fatty acids into cells and into mitochondria (11) . We did not observe a difference in CD36 in total membranes or mitochondria isolated from pooled gastrocnemius and quadriceps between Tbc1d1 Ϫ/Ϫ and Tbc1d1 ϩ/ϩ mice (Fig. 6F) . From these results, we conclude that female and male Tbc1d1 Ϫ/Ϫ mice have increased whole-body energy expenditure and skeletal muscle fatty acid oxidation. In males, these changes are associated with increased lipid clearance. Increased skeletal muscle fatty acid oxidation is not due to changes in ACC2, CPT1B, and CD36 expression.
DISCUSSION
Here, we describe similar skeletal muscle-specific and skeletal muscle type-dependent abnormalities in GLUT4 expression and glucose uptake in female and male Tbc1d1 Ϫ/Ϫ mice as previously reported in male Tbc1d1-deficient mice (4, 5, 8, 30, 31) . These findings are consistent with the distinct tissue distribution of Tbc1d1 in wild-type mice (5, 6, 31, 32) (Fig.  1C) . However, the molecular mechanisms by which these changes relate to Tbc1d1 function in controlling intracellular GLUT4 retention and GLUT4 cell surface exposure are currently unknown. In L6 myotubes, basal GLUT4 cell surface expression was increased upon siRNA-mediated knockdown of Tbc1d1 (15), suggesting a role for Tbc1d1 in intracellular GLUT4 retention and GLUT4 cell surface exposure. Our findings of increased GLUT4 plasma membrane association in large skeletal muscle under basal conditions are consistent with Tbc1d1 function in GLUT4 retention (Fig. 3C) . However, normal cell surface labeling of GLUT4 in Tbc1d1 Ϫ/Ϫ EDL under basal and insulin-stimulated conditions indicates no role for Tbc1d1 in regulating GLUT4 cell surface exposure (Fig.  3F) . In contrast, a recently published study, using a cell surface label and method similar to ours, describes that in Tbc1d1 Ϫ/Ϫ EDL the relative GLUT4 cell surface exposure is increased under basal conditions with no further change in response to insulin (4), thus concluding that Tbc1d1 controls GLUT4 cell surface exposure. One reason for the discrepancy may be low signal strength for labeled and total GLUT4 for Tbc1d1 Ϫ/Ϫ EDL in the recent study (4) , making reliable quantification difficult.
GLUT4 expressed at the cell surface determines glucose uptake in isolated skeletal muscle under basal and insulinstimulated conditions (27) . Decreased total GLUT4 expression with normal relative cell surface exposure could thus explain the impaired insulin-elicited glucose uptake in isolated Tbc1d1 Ϫ/Ϫ EDL (Figs. 2 and 3 ) (30, 31) . However, the increased insulin-stimulated glucose uptake in tibialis anterior and EDL and normal glucose uptake in gastrocnemius seen in vivo with the Tbc1d1 Ϫ/Ϫ mice is not consistent with decreased GLUT4 expression and normal relative GLUT4 cell surface exposure (Fig. 5) (31) . Additional factors determining glucose uptake in vivo must therefore come into play. This is further corroborated by the fact that insulin-stimulated glucose uptake in Tbc1d1 Ϫ/Ϫ mice is different between isolated EDL and EDL in vivo, impaired in the former ( Fig. 2A) (31) and increased in the latter (Fig. 5B) (31) . In vivo glucose uptake is also dependent on blood flow that is determined by capillary density and capillary recruitment in response to insulin (2) . Increased capillary density as an explanation for in vivo increased glucose uptake has been ruled out in an earlier study of Tbc1d1 Ϫ/Ϫ mice (31) .
How the lack of Tbc1d1 leads to decreased GLUT4 expression is currently unknown. Because GLUT4 mRNA levels are normal in Tbc1d1 Ϫ/Ϫ skeletal muscles, as demonstrated here and by others (4, 30, 31) , changes in GLUT4 degradation or translation attributable to accelerated GLUT4 trafficking to the plasma membrane or intracellular metabolic changes are likely responsible. Interestingly, protein expression of the insulinregulated aminopeptidase, a protein that colocalizes with GLUT4 in skeletal muscle and has similar trafficking characteristics as GLUT4 (16) , is normal in Tbc1d1 Ϫ/Ϫ mice (8, 31) . This makes intracellular metabolic abnormalities in the absence of Tbc1d1 more likely to mediate decreased GLUT4 protein expression.
Previous studies suggested little effect of Tbc1d1 deletion on glucose tolerance and insulin sensitivity when young male mice (3-4 mo old) on standard and high-fat diets were analyzed (4, 8, 30, 31) . We also found no impairment of glucose and insulin tolerance in chow-fed male Tbc1d1 Ϫ/Ϫ mice, at a young or old age. However, chow-fed female Tbc1d1 Ϫ/Ϫ mice showed impaired glucose tolerance independent of age and impaired insulin tolerance when they were older (Figs. 4 and  5F ). The difference between male and female Tbc1d1 Ϫ/Ϫ mice can currently not be explained by any sex-specific abnormalities in cellular or molecular parameters measured in our study.
We further find increased glucose levels under fasting conditions in males (Table 1 ) and in response to stress associated with anesthesia in both female and male Tbc1d1 Ϫ/Ϫ mice (Fig.  4A ). These abnormalities, although not dramatic, point toward subtle impairments in whole-body glucose homeostasis in, not only in female, but also male Tbc1d1 Ϫ/Ϫ mice. They cannot be explained by decreased in vivo glucose uptake in skeletal muscle or decreased glucose disposal in liver (Fig. 5) (31) . They are also not compatible with impaired insulin secretion because, in response to a glucose challenge, insulin levels are normal in Tbc1d1 Ϫ/Ϫ mice ( Fig. 4D) (8, 31) . It has recently been described that Tbc1d1 is expressed in glucagon-producing ␣-cells in pancreatic islets (26) . Future studies will need to address whether Tbc1d1 plays a role in glucagon secretion, and increased blood glucose levels in Tbc1d1 Ϫ/Ϫ mice under fasting and stressful conditions could be explained by elevated circulating glucagon levels. Loss of Tbc1d1 function in the brain where it is also expressed (32) could further contribute to dysregulation of glucose homeostasis as well as lipid metabolism and energy balance.
A major finding in previous studies was that male Tbc1d1 Ϫ/Ϫ mice weigh less on standard and high-fat diets (4, 5, 8) . In addition, they have lower body fat on a high-fat diet and lower lean mass on standard and high-fat diets but normal body length (8) . By contrast, we did not find any significant changes in body weight and body composition for male Tbc1d1 Ϫ/Ϫ mice on a chow diet, in agreement with some earlier studies (4, 30, 31) . However, female Tbc1d1 Ϫ/Ϫ mice showed consistently significantly lower body weight on a chow diet with no changes in body composition or body length. Lower body weights of the female Tbc1d1 Ϫ/Ϫ mice may be explained by their increased energy expenditure that is not compensated with increased food intake. Although male
Tbc1d1
Ϫ/Ϫ mice also had increased energy expenditure, an effect on body weight may have been negated by a simultaneous increase in food intake. Tbc1d1 mutations and singlenucleotide polymorphisms are associated with obesity in humans (18, 22, 24, 29) and body weight and body composition in animal studies (9, 38, 40) . Strikingly, the R125W mutation in Tbc1d1 was associated with severe obesity only in female pedigree (22, 29) , consistent with the more pronounced effect on body weight in female Tbc1d1
Ϫ/Ϫ mice observed in our study. The R125W mutation is located within the Tbc1d1 NH 2 -terminal phosphotyrosine-binding domain, and overexpression of the Tbc1d1 R125W mutant in rat tibialis anterior muscle decreases insulin-stimulated glucose uptake (1) .
In agreement with previously published results with male mice (4, 5, 8) , we observed increased fatty acid oxidation in skeletal muscle homogenates of Tbc1d1 Ϫ/Ϫ female and male mice (Fig. 6C) . How Tbc1d1 deletion leads to increased fatty acid oxidation is currently unknown. Decreased glucose availability can be ruled out as a cause because glucose uptake in vivo is normal or increased in skeletal muscles and in adipose tissues ( Fig. 5 ) (31) and glycogen levels in gastrocnemius are normal (4) . Increased cellular and mitochondrial fatty acid uptake mediated by the fatty acid translocase CD36 increases fatty acid oxidation (11) . Because CD36 trafficking is also regulated by insulin and exercise (11) , it was conceivable that Tbc1d1 could regulate CD36 subcellular distribution and thereby modify fatty acid oxidation. Consistent with this, Tbc1d1 deletion in cultured C2C12 myotubes leads to increased fatty acid uptake and oxidation (5) . Furthermore, male Tbc1d1 Ϫ/Ϫ mice clear fatty acids more efficiently after an oil gavage in vivo (Fig. 6E) . However, we did not find any changes in total membrane-bound CD36 and in mitochondrial CD36 (Fig. 6F) .
Previous studies measured increased fatty acid oxidation using intact isolated EDL and soleus muscles (4, 5, 8) . These studies could thus not differentiate whether increased fatty acid uptake was driving increased fatty acid oxidation or vice versa. Our experiment with gastrocnemius homogenates indicates that fatty acid oxidation is increased independent of fatty acid uptake. However, cellular rate-limiting enzymes regulating fatty acid oxidation, ACC2 and CPT1B, are normal in expression in soleus (8) and gastrocnemius (Fig. 6F) . A previous study also describes normal phosphorylation of ACC in Tbc1d1 Ϫ/Ϫ mice (8) . Recently, decreased activity of the mitochondrial enzyme ␤-hydroxyacyl-CoA dehydrogenase concomitant with decreased fatty acid oxidation was observed in soleus overexpressing Tbc1d1 (21) . This effect was independent of changes in CD36, ACC phosphorylation, and CPT1 mRNA expression. Future studies will need to determine the molecular mechanisms by which deletion of Tbc1d1 leads to increased fatty acid oxidation and whether they relate to a role of Tbc1d1 in regulating the trafficking of membrane proteins or to other currently unknown functions of Tbc1d1 in skeletal muscle or other tissues regulating fatty acid oxidation.
Although at the whole-body level we observe differences from Tbc1d1 Ϫ/Ϫ male mice used in earlier studies and differences between female and male Tbc1d1 Ϫ/Ϫ mice in our study, at the tissue level the changes are similar (4, 5, 8, 30, 31) . It may be that variations in the genetic background of the mouse strains used are responsible for some differences in the wholebody phenotype as discussed in (30) . Furthermore, the high expression of Tbc1d1 in specific skeletal muscles and low expression in adipose tissues makes the phenotype susceptible to differences in body composition. Differences in body composition together with sex-specific glucose and lipid utilization (35) may cause divergent female and male phenotypes in general (see lipid levels after oil gavage, Fig. 6 , D and E) and contribute to differences we observed between female and male mice upon Tbc1d1 deletion.
Among the known 42 TBC/Rab GAP domain-containing proteins, Tbc1d1 is most highly homologous to Tbc1d4, also known as Akt Substrate of 160 kDa (AS160) (10, 25) . Similar roles in the regulation of GLUT4 trafficking have been described for the two Rab GAPs (reviewed in Ref. 28) , and they both have multiple, but differentially regulated, phosphorylation sites (7, 33) . However, the two Rab GAPs are clearly distinct from each other in their tissue distributions (19, 32) . Adipose tissues express high levels of AS160 but little Tbc1d1. In skeletal muscle, both AS160 and Tbc1d1 are well expressed but at dissimilar levels in different muscles. We and other groups have characterized AS160
Ϫ/Ϫ mice (4, 19, 37) . Comparison of results between AS160
Ϫ/Ϫ and Tbc1d1 Ϫ/Ϫ mice reveals clear differences. Although they have similar abnormalities in glucose uptake in isolated skeletal muscle and in GLUT4 expression, these defects are present in different skeletal muscles consistent with their differential distribution, as demonstrated by this study and others (4, 5, 8, 19, 30, 31) . AS160 Ϫ/Ϫ mice show impaired glucose uptake and GLUT4 expression in soleus, whereas Tbc1d1 Ϫ/Ϫ mice do so in EDL. Similarly, GLUT4 expression is regulated at the protein level in AS160
Ϫ/Ϫ and Tbc1d1 Ϫ/Ϫ skeletal muscles (4, 19, 30, 31) . Also, there are similarities in their respective roles in the regulation of GLUT4 trafficking. Because AS160 Ϫ/Ϫ soleus and Tbc1d1
Ϫ/Ϫ EDL show normal GLUT4 cell surface exposure (19) , both GAPs may not play roles in regulating GLUT4 vesicle fusion. However, they clearly play roles in intracellular GLUT4 retention in large skeletal muscle. In AS160 Ϫ/Ϫ large skeletal muscles (gastro/quad), basal plasma membrane GLUT4 was increased to insulin-stimulated wild-type levels, and no further increase was observed in response to insulin (19) . In the same large skeletal muscles of Tbc1d1 Ϫ/Ϫ mice, plasma membrane GLUT4 was increased compared with wildtype under basal conditions but was lower than in insulinstimulated wild-type and further increased after insulin stimulation (Fig. 3C) . These differential findings suggest that AS160 may be responsible for full and Tbc1d1 only for partial intracellular GLUT4 retention. Whether the two Rab GAPs control different pools of GLUT4 in the same or in different skeletal muscle fibers remains to be determined. Distinct insulin-and exercise-regulated GLUT4 pools have been previously described (34) .
In AS160 Ϫ/Ϫ and Tbc1d1 Ϫ/Ϫ mice, defects in skeletal muscle glucose uptake observed in vivo are clearly different. Whereas insulin-stimulated glucose uptake is impaired in all skeletal muscles in AS160 Ϫ/Ϫ mice (19), it is normal or even increased in Tbc1d1 Ϫ/Ϫ skeletal muscle (Fig. 5 ) (31). These differences are most likely responsible for severely impaired and normal insulin tolerance tests in AS160 Ϫ/Ϫ (19) and Tbc1d1 Ϫ/Ϫ mice, respectively (Fig. 4) (30, 31) . With regard to energy and lipid homeostasis at the whole-body level, a recent study shows similarly decreased body weight and RER and increased fatty acid oxidation in male AS160
Ϫ/Ϫ and Tbc1d1 Ϫ/Ϫ mice on a standard diet (4). The specific molecular and cellular functions of AS160 and Tbc1d1 and thus their respective roles in the regulation of glucose, lipid, and energy homeostasis will need to be elucidated.
